Clinical Trials
3 trialsNCT07371208 2026-01-27
ST-A-TN
Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
NCT07179783 2025-09-18
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Tianjin Medical University Second Hospital
Phase 2 Recruiting
NCT07109284 2025-08-07
NeoSaciA
West China Hospital
Phase 2 Not yet recruiting